AARTI DRUGS LTD. - 524348 - Board Meeting Outcome for Outcome Of Board Meeting
Board approved the Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2023 and Buy-back of Equity Shares21-07-2023
21-07-2023
AARTI DRUGS LTD. - 524348 - Financial Results For The Quarter Ended June 30, 2023
Financial Results for the quarter ended June 30, 202321-07-2023
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts has been scheduled on Monday, July 24, 2023 at 11:00 A.M. IST to discuss the Company's financial performance for the Quarter ended June 30, 2023.18-07-2023
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation Loss of Share Certificate18-07-2023
AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Audited Financial Results And The Proposal Of Buyback
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2023 ,inter alia, to consider and approve Audited Financial Results and the proposal of buyback14-07-2023
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of Share Certificate.13-07-2023
AARTI DRUGS LTD. - 524348 - Reply To Clarification Sought With Respect To Increase In The Volume Of Security Across The Exchange
Reply to clarification sought with respect to increase in the volume of Security Across the exchange13-07-2023
AARTI DRUGS LTD. - 524348 - Clarification sought from Aarti Drugs Ltd
The Exchange has sought clarification from Aarti Drugs Ltd on July 13, 2023, with reference to Movement in Volume.The reply is awaited.13-07-2023
AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 201810-07-2023
AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificate10-07-2023